MAPKAPK5 and atrial fibrillation: Collectively, these findings suggest MAPKAPK5 contributes to AF by disrupting MAM-mediated calcium homeostasis, promoting mitochondrial dysfunction via oxidative stress, and amplifying inflammatory signaling—ultimately driving atrial structural/electrical remodeling and arrhythmogenesis.